131I 0 4 0 4 B-treatment
therapy 5 12 5 12 I-treatment
= 13 14 13 14 O
< 14 15 14 15 O
6 16 17 16 17 B-lower_bound
months 18 24 18 24 I-lower_bound
prior 25 30 25 30 I-lower_bound
to 31 33 31 33 O
registration 34 46 34 46 O
; 46 47 46 47 O
Note 48 52 48 52 O
: 52 53 52 53 O
131I 54 58 54 58 O
administered 59 71 59 71 O
solely 72 78 72 78 O
for 79 82 79 82 O
diagnostic 83 93 83 93 O
purposes 94 102 94 102 O
is 103 105 103 105 O
not 106 109 106 109 O
considered 110 120 110 120 O
131I 121 125 121 125 O
therapy 126 133 126 133 O

A 0 1 134 135 O
serum 2 7 136 141 B-clinical_variable
thyroglobulin 8 21 142 155 I-clinical_variable
of 22 24 156 158 O
10 25 27 159 161 B-lower_bound
ng 28 30 162 164 I-lower_bound
/ 30 31 164 165 I-lower_bound
ml 31 33 165 167 I-lower_bound
or 34 36 168 170 O
greater 37 44 171 178 O
in 45 47 179 181 O
the 48 51 182 185 O
context 52 59 186 193 O
of 60 62 194 196 O
suppressed 63 73 197 207 O
thyroid 74 81 208 215 O
- 81 82 215 216 O
stimulating 82 93 216 227 O
hormone 94 101 228 235 O
( 102 103 236 237 O
TSH 103 106 237 240 B-clinical_variable
) 106 107 240 241 O
( 108 109 242 243 O
TSH 109 112 243 246 O
= 113 114 247 248 O
< 114 115 248 249 O
0.4 116 119 250 253 B-upper_bound
mcU 120 123 254 257 I-upper_bound
/ 123 124 257 258 I-upper_bound
ml 124 126 258 260 I-upper_bound
) 126 127 260 261 O
= 128 129 262 263 O
< 129 130 263 264 O
28 131 133 265 267 B-upper_bound
days 134 138 268 272 I-upper_bound
prior 139 144 273 278 I-upper_bound
to 145 147 279 281 O
study 148 153 282 287 O
registration 154 166 288 300 O
; 166 167 300 301 O
use 168 171 302 305 O
of 172 174 306 308 O
any 175 178 309 312 O
thyroglobulin 179 192 313 326 B-treatment
assay 193 198 327 332 I-treatment
is 199 201 333 335 O
allowed 202 209 336 343 O
, 209 210 343 344 O
though 211 217 345 351 O
all 218 221 352 355 O
serum 222 227 356 361 O
thyroglobulin 228 241 362 375 O
measurements 242 254 376 388 O
for 255 258 389 392 O
study 259 264 393 398 O
purposes 265 273 399 407 O
must 274 278 408 412 O
be 279 281 413 415 O
conducted 282 291 416 425 O
with 292 296 426 430 O
the 297 300 431 434 O
same 301 305 435 439 O
thyroglobulin 306 319 440 453 O
assay 320 325 454 459 O

Able 0 4 460 464 O
to 5 7 465 467 O
swallow 8 15 468 475 O
and 16 19 476 479 O
retain 20 26 480 486 O
orally 27 33 487 493 O
- 33 34 493 494 O
administered 34 46 494 506 O
medication 47 57 507 517 B-treatment
with 58 62 518 522 O
no 63 65 523 525 O
clinically 66 76 526 536 O
significant 77 88 537 548 O
gastrointestinal 89 105 549 565 B-chronic_disease
abnormalities 106 119 566 579 I-chronic_disease
that 120 124 580 584 O
may 125 128 585 588 O
alter 129 134 589 594 O
absorption 135 145 595 605 O

Absolute 0 8 606 614 B-clinical_variable
neutrophil 9 19 615 625 I-clinical_variable
count 20 25 626 631 I-clinical_variable
( 26 27 632 633 I-clinical_variable
ANC 27 30 633 636 I-clinical_variable
) 30 31 636 637 I-clinical_variable
> 32 33 638 639 O
= 33 34 639 640 O
1500 35 39 641 645 B-lower_bound
/ 39 40 645 646 I-lower_bound
mm^3 40 44 646 650 I-lower_bound
( 45 46 651 652 O
obtained 46 54 652 660 O
= 55 56 661 662 O
< 56 57 662 663 O
28 58 60 664 666 B-upper_bound
days 61 65 667 671 I-upper_bound
prior 66 71 672 677 I-upper_bound
to 72 74 678 680 O
randomization 75 88 681 694 O
) 88 89 694 695 O

Aspartate 0 9 696 705 B-clinical_variable
transaminase 10 22 706 718 I-clinical_variable
( 23 24 719 720 I-clinical_variable
AST 24 27 720 723 I-clinical_variable
) 27 28 723 724 I-clinical_variable
= 29 30 725 726 O
< 30 31 726 727 B-upper_bound
2.5 32 35 728 731 I-upper_bound
x 36 37 732 733 I-upper_bound
ULN 38 41 734 737 I-upper_bound
( 42 43 738 739 O
or 43 45 739 741 O
= 46 47 742 743 O
< 47 48 743 744 O
5 49 50 745 746 O
x 51 52 747 748 O
ULN 53 56 749 752 O
in 57 59 753 755 O
presence 60 68 756 764 O
of 69 71 765 767 O
liver 72 77 768 773 B-cancer
metastases 78 88 774 784 I-cancer
) 88 89 784 785 O
( 90 91 786 787 O
obtained 91 99 787 795 O
= 100 101 796 797 O
< 101 102 797 798 O
28 103 105 799 801 B-upper_bound
days 106 110 802 806 I-upper_bound
prior 111 116 807 812 I-upper_bound
to 117 119 813 815 O
randomization 120 133 816 829 O
) 133 134 829 830 O

Creatinine 0 10 831 841 B-clinical_variable
= 11 12 842 843 O
< 12 13 843 844 O
1.5 14 17 845 848 B-upper_bound
mg 18 20 849 851 I-upper_bound
/ 20 21 851 852 I-upper_bound
dL 21 23 852 854 I-upper_bound
OR 24 26 855 857 O
calculated 27 37 858 868 B-clinical_variable
creatinine 38 48 869 879 I-clinical_variable
clearance 49 58 880 889 I-clinical_variable
of 59 61 890 892 O
> 62 63 893 894 O
= 63 64 894 895 O
50 65 67 896 898 B-lower_bound
ml 68 70 899 901 I-lower_bound
/ 70 71 901 902 I-lower_bound
min 71 74 902 905 I-lower_bound
by 75 77 906 908 O
either 78 84 909 915 O
the 85 88 916 919 O
Cockcroft 89 98 920 929 O
- 98 99 929 930 O
Gault 99 104 930 935 O
formula 105 112 936 943 O
or 113 115 944 946 O
24 116 118 947 949 O
- 118 119 949 950 O
hours 119 124 950 955 O
urine 125 130 956 961 O
collection 131 141 962 972 O
analysis 142 150 973 981 O
( 151 152 982 983 O
obtained 152 160 983 991 O
= 161 162 992 993 O
< 162 163 993 994 O
28 164 166 995 997 B-upper_bound
days 167 171 998 1002 I-upper_bound
prior 172 177 1003 1008 I-upper_bound
to 178 180 1009 1011 O
randomization 181 194 1012 1025 O
) 194 195 1025 1026 O

Diagnosis 0 9 1027 1036 O
of 10 12 1037 1039 O
recurrent 13 22 1040 1049 B-cancer
and/or 23 29 1050 1056 O
metastatic 30 40 1057 1067 B-cancer
thyroid 41 48 1068 1075 I-cancer
cancer 49 55 1076 1082 I-cancer

Eastern 0 7 1083 1090 B-clinical_variable
Cooperative 8 19 1091 1102 I-clinical_variable
Oncology 20 28 1103 1111 I-clinical_variable
Group 29 34 1112 1117 I-clinical_variable
( 35 36 1118 1119 I-clinical_variable
ECOG 36 40 1119 1123 I-clinical_variable
) 40 41 1123 1124 I-clinical_variable
performance 42 53 1125 1136 I-clinical_variable
status 54 60 1137 1143 I-clinical_variable
( 61 62 1144 1145 I-clinical_variable
PS 62 64 1145 1147 I-clinical_variable
) 64 65 1147 1148 I-clinical_variable
0 66 67 1149 1150 B-lower_bound
, 67 68 1150 1151 O
1 69 70 1152 1153 O
or 71 73 1154 1156 O
2 74 75 1157 1158 B-upper_bound

External 0 8 1159 1167 B-treatment
beam 9 13 1168 1172 I-treatment
radiation 14 23 1173 1182 I-treatment
therapy 24 31 1183 1190 I-treatment
= 32 33 1191 1192 O
< 33 34 1192 1193 O
28 35 37 1194 1196 B-upper_bound
days 38 42 1197 1201 I-upper_bound
prior 43 48 1202 1207 I-upper_bound
to 49 51 1208 1210 O
registration 52 64 1211 1223 O
; 64 65 1223 1224 O
note 66 70 1225 1229 O
: 70 71 1229 1230 O
previous 72 80 1231 1239 B-treatment
treatment 81 90 1240 1249 I-treatment
with 91 95 1250 1254 I-treatment
radiation 96 105 1255 1264 I-treatment
is 106 108 1265 1267 O
allowed 109 116 1268 1275 O
if 117 119 1276 1278 O
the 120 123 1279 1282 O
investigator 124 136 1283 1295 O
judges 137 143 1296 1302 O
it 144 146 1303 1305 O
will 147 151 1306 1310 O
not 152 155 1311 1314 O
compromise 156 166 1315 1325 O
patient 167 174 1326 1333 O
safety 175 181 1334 1340 O
on 182 184 1341 1343 O
the 185 188 1344 1347 O
study 189 194 1348 1353 O

For 0 3 1354 1357 O
patients 4 12 1358 1366 O
with 13 17 1367 1371 O
non 18 21 1372 1375 O
- 21 22 1375 1376 O
measurable 22 32 1376 1386 O
, 32 33 1386 1387 O
structural 34 44 1388 1398 B-chronic_disease
disease 45 52 1399 1406 I-chronic_disease

Having 0 6 1407 1413 O
been 7 11 1414 1418 O
treated 12 19 1419 1426 O
with 20 24 1427 1431 O
a 25 26 1432 1433 O
total 27 32 1434 1439 B-clinical_variable
cumulative 33 43 1440 1450 I-clinical_variable
( 44 45 1451 1452 I-clinical_variable
lifetime 45 53 1452 1460 I-clinical_variable
) 53 54 1460 1461 I-clinical_variable
131I 55 59 1462 1466 B-treatment
therapeutic 60 71 1467 1478 I-treatment
activity 72 80 1479 1487 I-treatment
> 81 82 1488 1489 O
800 83 86 1490 1493 B-lower_bound
mCi 87 90 1494 1497 I-lower_bound
( 91 92 1498 1499 O
excluding 92 101 1499 1508 O
131I 102 106 1509 1513 B-treatment
activity 107 115 1514 1522 I-treatment
administered 116 128 1523 1535 O
for 129 132 1536 1539 O
diagnostic 133 143 1540 1550 O
scans 144 149 1551 1556 O
) 149 150 1556 1557 O

Hemoglobin 0 10 1558 1568 B-clinical_variable
> 11 12 1569 1570 O
9.0 13 16 1571 1574 B-lower_bound
g 17 18 1575 1576 I-lower_bound
/ 18 19 1576 1577 I-lower_bound
dL 19 21 1577 1579 I-lower_bound
( 22 23 1580 1581 O
obtained 23 31 1581 1589 O
= 32 33 1590 1591 O
< 33 34 1591 1592 O
28 35 37 1593 1595 B-upper_bound
days 38 42 1596 1600 I-upper_bound
prior 43 48 1601 1606 I-upper_bound
to 49 51 1607 1609 O
randomization 52 65 1610 1623 O
) 65 66 1623 1624 O

Histological 0 12 1625 1637 O
or 13 15 1638 1640 O
cytological 16 27 1641 1652 O
confirmation 28 40 1653 1665 O
of 41 43 1666 1668 O
thyroid 44 51 1669 1676 B-cancer
carcinoma 52 61 1677 1686 I-cancer
of 62 64 1687 1689 O
follicular 65 75 1690 1700 O
origin 76 82 1701 1707 O
( 83 84 1708 1709 O
including 84 93 1709 1718 O
papillary 94 103 1719 1728 O
, 103 104 1728 1729 O
follicular 105 115 1730 1740 O
, 115 116 1740 1741 O
or 117 119 1742 1744 O
poorly 120 126 1745 1751 O
differentiated 127 141 1752 1766 O
subtypes 142 150 1767 1775 O
and 151 154 1776 1779 O
their 155 160 1780 1785 O
respective 161 171 1786 1796 O
variants 172 180 1797 1805 O
) 180 181 1805 1806 O

Immunocompromised 0 17 1807 1824 B-chronic_disease
patients 18 26 1825 1833 O
and 27 30 1834 1837 O
patients 31 39 1838 1846 O
known 40 45 1847 1852 O
to 46 48 1853 1855 O
be 49 51 1856 1858 O
human 52 57 1859 1864 B-chronic_disease
immunodeficiency 58 74 1865 1881 I-chronic_disease
virus 75 80 1882 1887 I-chronic_disease
( 81 82 1888 1889 I-chronic_disease
HIV 82 85 1889 1892 I-chronic_disease
) 85 86 1892 1893 I-chronic_disease
positive 87 95 1894 1902 O
and 96 99 1903 1906 O
currently 100 109 1907 1916 O
receiving 110 119 1917 1926 O
antiretroviral 120 134 1927 1941 B-treatment
therapy 135 142 1942 1949 I-treatment

It 0 2 1950 1952 O
is 3 5 1953 1955 O
noted 6 11 1956 1961 O
to 12 14 1962 1964 O
be 15 17 1965 1967 O
RAI 18 21 1968 1971 B-treatment
- 21 22 1971 1972 O
avid 22 26 1972 1976 O
on 27 29 1977 1979 O
radioactive 30 41 1980 1991 B-treatment
iodine 42 48 1992 1998 I-treatment
imaging 49 56 1999 2006 I-treatment
( 57 58 2007 2008 O
diagnostic 58 68 2008 2018 O
or 69 71 2019 2021 O
post 72 76 2022 2026 B-treatment
- 76 77 2026 2027 I-treatment
therapy 77 84 2027 2034 I-treatment
whole 85 90 2035 2040 O
body 91 95 2041 2045 O
scans 96 101 2046 2051 O
acceptable 102 112 2052 2062 O
) 112 113 2062 2063 O
and 114 117 2064 2067 O
it 118 120 2068 2070 O
measures 121 129 2071 2079 O
> 130 131 2080 2081 O
= 131 132 2081 2082 O
1 133 134 2083 2084 B-lower_bound
cm 135 137 2085 2087 I-lower_bound
in 138 140 2088 2090 O
the 141 144 2091 2094 O
long 145 149 2095 2099 O
axis 150 154 2100 2104 O

It 0 2 2105 2107 O
is 3 5 2108 2110 O
pathologically 6 20 2111 2125 O
proven 21 27 2126 2132 O
to 28 30 2133 2135 O
be 31 33 2136 2138 O
involved 34 42 2139 2147 O
with 43 47 2148 2152 O
thyroid 48 55 2153 2160 B-cancer
cancer 56 62 2161 2167 I-cancer
( 63 64 2168 2169 O
by 64 66 2169 2171 O
cytology 67 75 2172 2180 O
or 76 78 2181 2183 O
pathology 79 88 2184 2193 O
) 88 89 2193 2194 O
and 90 93 2195 2198 O
it 94 96 2199 2201 O
measures 97 105 2202 2210 O
> 106 107 2211 2212 O
= 107 108 2212 2213 O
1 109 110 2214 2215 B-lower_bound
cm 111 113 2216 2218 I-lower_bound
in 114 116 2219 2221 O
the 117 120 2222 2225 O
long 121 125 2226 2230 O
axis 126 130 2231 2235 O

Its 0 3 2236 2239 O
short 4 9 2240 2245 B-clinical_variable
axis 10 14 2246 2250 I-clinical_variable
is 15 17 2251 2253 O
> 18 19 2254 2255 O
= 19 20 2255 2256 O
1.5 21 24 2257 2260 B-lower_bound
cm 25 27 2261 2263 I-lower_bound
when 28 32 2264 2268 O
assessed 33 41 2269 2277 O
by 42 44 2278 2280 O
computed 45 53 2281 2289 B-treatment
tomography 54 64 2290 2300 I-treatment
( 65 66 2301 2302 I-treatment
CT 66 68 2302 2304 I-treatment
) 68 69 2304 2305 I-treatment
scan 70 74 2306 2310 I-treatment
NOTE 75 79 2311 2315 O
2 80 81 2316 2317 O
: 81 82 2317 2318 O
Patients 83 91 2319 2327 O
only 92 96 2328 2332 O
with 97 101 2333 2337 O
biochemical 102 113 2338 2349 O
evidence 114 122 2350 2358 O
of 123 125 2359 2361 O
disease 126 133 2362 2369 O
without 134 141 2370 2377 O
structural 142 152 2378 2388 O
evidence 153 161 2389 2397 O
of 162 164 2398 2400 O
cancer 165 171 2401 2407 B-cancer
are 172 175 2408 2411 O
not 176 179 2412 2415 O
eligible 180 188 2416 2424 O
for 189 192 2425 2428 O
this 193 197 2429 2433 O
study 198 203 2434 2439 O

Men 0 3 2440 2443 B-gender
or 4 6 2444 2446 I-gender
women 7 12 2447 2452 I-gender
of 13 15 2453 2455 O
childbearing 16 28 2456 2468 O
potential 29 38 2469 2478 O
who 39 42 2479 2482 O
are 43 46 2483 2486 O
unwilling 47 56 2487 2496 B-contraception_consent
to 57 59 2497 2499 I-contraception_consent
employ 60 66 2500 2506 I-contraception_consent
adequate 67 75 2507 2515 I-contraception_consent
contraception 76 89 2516 2529 I-contraception_consent

Modification 0 12 2530 2542 O
of 13 15 2543 2545 O
the 16 19 2546 2549 O
RECIST 20 26 2550 2556 O
v1.1 27 31 2557 2561 O
measurable 32 42 2562 2572 O
disease 43 50 2573 2580 O
criteria 51 59 2581 2589 O
includes 60 68 2590 2598 O
a 69 70 2599 2600 O
change 71 77 2601 2607 O
in 78 80 2608 2610 O
the 81 84 2611 2614 O
definition 85 95 2615 2625 O
of 96 98 2626 2628 O
what 99 103 2629 2633 O
is 104 106 2634 2636 O
considered 107 117 2637 2647 O
a 118 119 2648 2649 O
measurable 120 130 2650 2660 O
malignant 131 140 2661 2670 B-cancer
lymph 141 146 2671 2676 I-cancer
node 147 151 2677 2681 I-cancer

Negative 0 8 2682 2690 B-pregnancy
pregnancy 9 18 2691 2700 I-pregnancy
test 19 23 2701 2705 O
performed 24 33 2706 2715 O
= 34 35 2716 2717 O
< 35 36 2717 2718 O
7 37 38 2719 2720 B-upper_bound
days 39 43 2721 2725 I-upper_bound
prior 44 49 2726 2731 I-upper_bound
to 50 52 2732 2734 O
registration 53 65 2735 2747 O
for 66 69 2748 2751 O
women 70 75 2752 2757 B-gender
of 76 78 2758 2760 O
childbearing 79 91 2761 2773 O
potential 92 101 2774 2783 O
only 102 106 2784 2788 O

Not 0 3 2789 2792 O
willing 4 11 2793 2800 O
to 12 14 2801 2803 O
discontinue 15 26 2804 2815 O
use 27 30 2816 2819 O
of 31 33 2820 2822 O
supplemental 34 46 2823 2835 B-treatment
vitamin 47 54 2836 2843 I-treatment
E 55 56 2844 2845 I-treatment

Nursing 0 7 2846 2853 O
women 8 13 2854 2859 B-gender

Other 0 5 2860 2865 O
active 6 12 2866 2872 O
malignancy 13 23 2873 2883 B-clinical_variable
= 24 25 2884 2885 O
< 25 26 2885 2886 O
2 27 28 2887 2888 B-upper_bound
years 29 34 2889 2894 I-upper_bound
prior 35 40 2895 2900 I-upper_bound
to 41 43 2901 2903 O
registration 44 56 2904 2916 O
that 57 61 2917 2921 O
will 62 66 2922 2926 O
interfere 67 76 2927 2936 O
with 77 81 2937 2941 O
conduct 82 89 2942 2949 O
of 90 92 2950 2952 O
this 93 97 2953 2957 O
trial 98 103 2958 2963 O

Platelet 0 8 2964 2972 B-clinical_variable
count 9 14 2973 2978 I-clinical_variable
> 15 16 2979 2980 O
= 16 17 2980 2981 O
100,000 18 25 2982 2989 B-lower_bound
/ 25 26 2989 2990 I-lower_bound
mm^3 26 30 2990 2994 I-lower_bound
( 31 32 2995 2996 O
obtained 32 40 2996 3004 O
= 41 42 3005 3006 O
< 42 43 3006 3007 O
28 44 46 3008 3010 B-upper_bound
days 47 51 3011 3015 I-upper_bound
prior 52 57 3016 3021 I-upper_bound
to 58 60 3022 3024 O
randomization 61 74 3025 3038 O
) 74 75 3038 3039 O

Pregnant 0 8 3040 3048 B-pregnancy
women 9 14 3049 3054 B-gender

Prior 0 5 3055 3060 O
exposure 6 14 3061 3069 O
to 15 17 3070 3072 O
mitogen 18 25 3073 3080 B-treatment
- 25 26 3080 3081 I-treatment
activated 26 35 3081 3090 I-treatment
protein 36 43 3091 3098 I-treatment
kinase 44 50 3099 3105 I-treatment
kinase 51 57 3106 3112 I-treatment
( 58 59 3113 3114 I-treatment
MEK 59 62 3114 3117 I-treatment
) 62 63 3117 3118 I-treatment
, 63 64 3118 3119 O
RAS 65 68 3120 3123 B-treatment
, 68 69 3123 3124 O
or 70 72 3125 3127 O
RAF 73 76 3128 3131 B-treatment
inhibitors 77 87 3132 3142 I-treatment
( 88 89 3143 3144 O
note 89 93 3144 3148 O
: 93 94 3148 3149 O
previous 95 103 3150 3158 O
exposure 104 112 3159 3167 O
to 113 115 3168 3170 O
sorafenib 116 125 3171 3180 B-treatment
is 126 128 3181 3183 O
allowed 129 136 3184 3191 O
) 136 137 3191 3192 O
OR 138 140 3193 3195 O
history 141 148 3196 3203 O
of 149 151 3204 3206 O
hypersensitivity 152 168 3207 3223 O
to 169 171 3224 3226 O
selumetinib 172 183 3227 3238 B-allergy_name
, 183 184 3238 3239 O
thyrotropin 185 196 3240 3251 B-allergy_name
alpha 197 202 3252 3257 I-allergy_name
( 203 204 3258 3259 I-allergy_name
Thyrogen 204 212 3259 3267 I-allergy_name
) 212 213 3267 3268 I-allergy_name
, 213 214 3268 3269 O
or 215 217 3270 3272 O
any 218 221 3273 3276 O
excipient 222 231 3277 3286 B-allergy_name
agents 232 238 3287 3293 I-allergy_name

RAI 0 3 3294 3297 O
- 3 4 3297 3298 O
avid 4 8 3298 3302 O
lesion 9 15 3303 3309 O
on 16 18 3310 3312 O
a 19 20 3313 3314 O
radioiodine 21 32 3315 3326 B-treatment
scan 33 37 3327 3331 I-treatment
( 38 39 3332 3333 O
a 39 40 3333 3334 O
diagnostic 41 51 3335 3345 B-treatment
, 51 52 3345 3346 O
post 53 57 3347 3351 B-treatment
- 57 58 3351 3352 I-treatment
therapy 58 65 3352 3359 I-treatment
, 65 66 3359 3360 O
or 67 69 3361 3363 O
post 70 74 3364 3368 B-treatment
- 74 75 3368 3369 I-treatment
ablation 75 83 3369 3377 I-treatment
scans 84 89 3378 3383 I-treatment
) 89 90 3383 3384 O
performed 91 100 3385 3394 O
= 101 102 3395 3396 O
< 102 103 3396 3397 O
24 104 106 3398 3400 B-upper_bound
months 107 113 3401 3407 I-upper_bound
prior 114 119 3408 3413 I-upper_bound
to 120 122 3414 3416 O
registration 123 135 3417 3429 O
, 135 136 3429 3430 O
which 137 142 3431 3436 O
suggests 143 151 3437 3445 O
that 152 156 3446 3450 O
therapy 157 164 3451 3458 B-treatment
with 165 169 3459 3463 I-treatment
131I 170 174 3464 3468 I-treatment
is 175 177 3469 3471 O
justifiable 178 189 3472 3483 O
in 190 192 3484 3486 O
the 193 196 3487 3490 O
judgment 197 205 3491 3499 O
of 206 208 3500 3502 O
the 209 212 3503 3506 O
investigator 213 225 3507 3519 O

Received 0 8 3520 3528 O
iodinated 9 18 3529 3538 B-treatment
intravenous 19 30 3539 3550 I-treatment
contrast 31 39 3551 3559 I-treatment
within 40 46 3560 3566 O
= 47 48 3567 3568 O
< 48 49 3568 3569 O
2 50 51 3570 3571 B-upper_bound
months 52 58 3572 3578 I-upper_bound
of 59 61 3579 3581 O
registration 62 74 3582 3594 O
; 74 75 3594 3595 O
avoidance 76 85 3596 3605 O
of 86 88 3606 3608 O
iodinated 89 98 3609 3618 B-treatment
oral 99 103 3619 3623 I-treatment
contrast 104 112 3624 3632 I-treatment
is 113 115 3633 3635 O
also 116 120 3636 3640 O
preferred 121 130 3641 3650 O
but 131 134 3651 3654 O
not 135 138 3655 3658 O
strictly 139 147 3659 3667 O
required 148 156 3668 3676 O
for 157 160 3677 3680 O
study 161 166 3681 3686 O
enrollment 167 177 3687 3697 O

Receiving 0 9 3698 3707 O
any 10 13 3708 3711 O
other 14 19 3712 3717 O
investigational 20 35 3718 3733 B-treatment
agent 36 41 3734 3739 I-treatment
which 42 47 3740 3745 O
would 48 53 3746 3751 O
be 54 56 3752 3754 O
considered 57 67 3755 3765 O
as 68 70 3766 3768 O
a 71 72 3769 3770 O
treatment 73 82 3771 3780 B-treatment
for 83 86 3781 3784 O
the 87 90 3785 3788 O
primary 91 98 3789 3796 B-cancer
neoplasm 99 107 3797 3805 I-cancer

Symptomatic 0 11 3806 3817 O
or 12 14 3818 3820 O
untreated 15 24 3821 3830 O
leptomeningeal 25 39 3831 3845 B-cancer
disease 40 47 3846 3853 I-cancer
, 47 48 3853 3854 O
brain 49 54 3855 3860 B-cancer
metastasis 55 65 3861 3871 I-cancer
, 65 66 3871 3872 O
or 67 69 3873 3875 O
spinal 70 76 3876 3882 B-chronic_disease
cord 77 81 3883 3887 I-chronic_disease
compression 82 93 3888 3899 I-chronic_disease

Total 0 5 3900 3905 B-clinical_variable
bilirubin 6 15 3906 3915 I-clinical_variable
= 16 17 3916 3917 O
< 17 18 3917 3918 O
1.5 19 22 3919 3922 B-upper_bound
x 23 24 3923 3924 I-upper_bound
upper 25 30 3925 3930 I-upper_bound
limit 31 36 3931 3936 I-upper_bound
of 37 39 3937 3939 I-upper_bound
normal 40 46 3940 3946 I-upper_bound
( 47 48 3947 3948 I-upper_bound
ULN 48 51 3948 3951 I-upper_bound
) 51 52 3951 3952 I-upper_bound
( 53 54 3953 3954 O
obtained 54 62 3954 3962 O
= 63 64 3963 3964 O
< 64 65 3964 3965 O
28 66 68 3966 3968 B-upper_bound
days 69 73 3969 3973 I-upper_bound
prior 74 79 3974 3979 I-upper_bound
to 80 82 3980 3982 O
randomization 83 96 3983 3996 O
) 96 97 3996 3997 O

Treatment 0 9 3998 4007 B-treatment
with 10 14 4008 4012 I-treatment
chemotherapy 15 27 4013 4025 I-treatment
or 28 30 4026 4028 O
targeted 31 39 4029 4037 B-treatment
therapy 40 47 4038 4045 I-treatment
( 48 49 4046 4047 O
e.g. 49 53 4047 4051 O
tyrosine 54 62 4052 4060 B-treatment
kinase 63 69 4061 4067 I-treatment
inhibitor 70 79 4068 4077 I-treatment
) 79 80 4077 4078 O
= 81 82 4079 4080 O
< 82 83 4080 4081 O
28 84 86 4082 4084 B-upper_bound
days 87 91 4085 4089 I-upper_bound
prior 92 97 4090 4095 I-upper_bound
to 98 100 4096 4098 O
registration 101 113 4099 4111 O

Unable 0 6 4112 4118 O
to 7 9 4119 4121 O
follow 10 16 4122 4128 O
a 17 18 4129 4130 O
low 19 22 4131 4134 O
iodine 23 29 4135 4141 O
diet 30 34 4142 4146 O
or 35 37 4147 4149 O
requiring 38 47 4150 4159 B-treatment
medication 48 58 4160 4170 I-treatment
with 59 63 4171 4175 I-treatment
high 64 68 4176 4180 I-treatment
content 69 76 4181 4188 I-treatment
in 77 79 4189 4191 I-treatment
iodide 80 86 4192 4198 I-treatment
( 87 88 4199 4200 O
e.g. 88 92 4200 4204 O
, 92 93 4204 4205 O
amiodarone 94 104 4206 4216 B-treatment
) 104 105 4216 4217 O

Uncontrolled 0 12 4218 4230 O
intercurrent 13 25 4231 4243 O
illness 26 33 4244 4251 O
including 34 43 4252 4261 O
, 43 44 4261 4262 O
but 45 48 4263 4266 O
not 49 52 4267 4270 O
limited 53 60 4271 4278 O
to 61 63 4279 4281 O
, 63 64 4281 4282 O
ongoing 65 72 4283 4290 O
or 73 75 4291 4293 O
active 76 82 4294 4300 B-chronic_disease
infection 83 92 4301 4310 I-chronic_disease
, 92 93 4310 4311 O
hepatitis 94 103 4312 4321 B-chronic_disease
B 104 105 4322 4323 I-chronic_disease
infection 106 115 4324 4333 I-chronic_disease
, 115 116 4333 4334 O
hepatitis 117 126 4335 4344 B-chronic_disease
C 127 128 4345 4346 I-chronic_disease
infection 129 138 4347 4356 I-chronic_disease
, 138 139 4356 4357 O
symptomatic 140 151 4358 4369 O
congestive 152 162 4370 4380 B-chronic_disease
heart 163 168 4381 4386 I-chronic_disease
failure 169 176 4387 4394 I-chronic_disease
, 176 177 4394 4395 O
unstable 178 186 4396 4404 B-chronic_disease
angina 187 193 4405 4411 I-chronic_disease
pectoris 194 202 4412 4420 I-chronic_disease
, 202 203 4420 4421 O
cardiac 204 211 4422 4429 B-chronic_disease
arrhythmia 212 222 4430 4440 I-chronic_disease
, 222 223 4440 4441 O
or 224 226 4442 4444 O
psychiatric 227 238 4445 4456 B-chronic_disease
illness 239 246 4457 4464 I-chronic_disease
/ 246 247 4464 4465 I-chronic_disease
social 247 253 4465 4471 I-chronic_disease
situations 254 264 4472 4482 I-chronic_disease
that 265 269 4483 4487 O
would 270 275 4488 4493 O
limit 276 281 4494 4499 O
compliance 282 292 4500 4510 O
with 293 297 4511 4515 O
study 298 303 4516 4521 O
requirements 304 316 4522 4534 O

Unresolved 0 10 4535 4545 O
toxicity 11 19 4546 4554 O
> 20 21 4555 4556 O
Common 22 28 4557 4563 B-lower_bound
Terminology 29 40 4564 4575 I-lower_bound
Criteria 41 49 4576 4584 I-lower_bound
for 50 53 4585 4588 I-lower_bound
Adverse 54 61 4589 4596 I-lower_bound
Events 62 68 4597 4603 I-lower_bound
( 69 70 4604 4605 I-lower_bound
CTCAE 70 75 4605 4610 I-lower_bound
) 75 76 4610 4611 I-lower_bound
grade 77 82 4612 4617 I-lower_bound
2 83 84 4618 4619 I-lower_bound
from 85 89 4620 4624 O
previous 90 98 4625 4633 O
anti 99 103 4634 4638 B-treatment
- 103 104 4638 4639 I-treatment
cancer 104 110 4639 4645 I-treatment
therapy 111 118 4646 4653 I-treatment

Willing 0 7 4654 4661 O
to 8 10 4662 4664 O
provide 11 18 4665 4672 O
mandatory 19 28 4673 4682 O
archival 29 37 4683 4691 O
tumor 38 43 4692 4697 B-cancer
tissue 44 50 4698 4704 O
( 51 52 4705 4706 O
block 52 57 4706 4711 O
or 58 60 4712 4714 O
minimum 61 68 4715 4722 O
of 69 71 4723 4725 O
30 72 74 4726 4728 B-lower_bound
unstained 75 84 4729 4738 O
slides 85 91 4739 4745 O
from 92 96 4746 4750 O
a 97 98 4751 4752 O
primary 99 106 4753 4760 B-cancer
or 107 109 4761 4763 I-cancer
recurrent 110 119 4764 4773 I-cancer
/ 119 120 4773 4774 I-cancer
metastatic 120 130 4774 4784 I-cancer
thyroid 131 138 4785 4792 I-cancer
cancer 139 145 4793 4799 I-cancer
) 145 146 4799 4800 O
for 147 150 4801 4804 O
correlative 151 162 4805 4816 O
research 163 171 4817 4825 O
purposes 172 180 4826 4834 O

during 0 6 4835 4841 O
the 7 10 4842 4845 O
Active 11 17 4846 4852 O
Monitoring 18 28 4853 4863 O
Phase 29 34 4864 4869 O
of 35 37 4870 4872 O
a 38 39 4873 4874 O
study 40 45 4875 4880 O
( 46 47 4881 4882 O
i.e. 47 51 4882 4886 O
, 51 52 4886 4887 O
active 53 59 4888 4894 B-treatment
treatment 60 69 4895 4904 I-treatment
and 70 73 4905 4908 O
observation 74 85 4909 4920 O
) 85 86 4920 4921 O
, 86 87 4921 4922 O
participants 88 100 4923 4935 O
must 101 105 4936 4940 O
be 106 108 4941 4943 O
willing 109 116 4944 4951 O
to 117 119 4952 4954 O
return 120 126 4955 4961 O
to 127 129 4962 4964 O
the 130 133 4965 4968 O
consenting 134 144 4969 4979 O
institution 145 156 4980 4991 O
for 157 160 4992 4995 O
follow 161 167 4996 5002 O
- 167 168 5002 5003 O
up 168 170 5003 5005 O

medullary 0 9 5006 5015 B-cancer
and 10 13 5016 5019 O
anaplastic 14 24 5020 5030 B-cancer
thyroid 25 32 5031 5038 I-cancer
cancers 33 40 5039 5046 I-cancer
are 41 44 5047 5050 O
excluded 45 53 5051 5059 O
; 53 54 5059 5060 O
Hurthle 55 62 5061 5068 B-cancer
cell 63 67 5069 5073 I-cancer
carcinomas 68 78 5074 5084 I-cancer
are 79 82 5085 5088 O
excluded 83 91 5089 5097 O
( 92 93 5098 5099 O
defined 93 100 5099 5106 O
as 101 103 5107 5109 O
having 104 110 5110 5116 O
an 111 113 5117 5119 O
invasive 114 122 5120 5128 B-cancer
tumor 123 128 5129 5134 I-cancer
composed 129 137 5135 5143 O
of 138 140 5144 5146 O
> 141 142 5147 5148 O
75 143 145 5149 5151 B-lower_bound
% 145 146 5151 5152 I-lower_bound
oncocytic 147 156 5153 5162 I-lower_bound
[ 157 158 5163 5164 I-lower_bound
Hurthle 158 165 5164 5171 I-lower_bound
] 165 166 5171 5172 I-lower_bound
cells 167 172 5173 5178 I-lower_bound
lacking 173 180 5179 5186 O
the 181 184 5187 5190 O
nuclear 185 192 5191 5198 O
features 193 201 5199 5207 O
of 202 204 5208 5210 O
papillary 205 214 5211 5220 B-cancer
carcinoma 215 224 5221 5230 I-cancer
, 224 225 5230 5231 O
tumor 226 231 5232 5237 B-cancer
necrosis 232 240 5238 5246 I-cancer
, 240 241 5246 5247 O
and 242 245 5248 5251 O
marked 246 252 5252 5258 O
mitotic 253 260 5259 5266 O
activity 261 269 5267 5275 O
) 269 270 5275 5276 O

non 0 3 5277 5280 B-cancer
- 3 4 5280 5281 I-cancer
melanotic 4 13 5281 5290 I-cancer
skin 14 18 5291 5295 I-cancer
cancer 19 25 5296 5302 I-cancer
or 26 28 5303 5305 O
carcinoma 29 38 5306 5315 B-cancer
- 38 39 5315 5316 I-cancer
in 39 41 5316 5318 I-cancer
- 41 42 5318 5319 I-cancer
situ 42 46 5319 5323 I-cancer
of 47 49 5324 5326 I-cancer
the 50 53 5327 5330 I-cancer
cervix 54 60 5331 5337 I-cancer
; 60 61 5337 5338 O
NOTE 62 66 5339 5343 O
: 66 67 5343 5344 O
if 68 70 5345 5347 O
there 71 76 5348 5353 O
is 77 79 5354 5356 O
a 80 81 5357 5358 O
history 82 89 5359 5366 O
of 90 92 5367 5369 O
prior 93 98 5370 5375 O
malignancy 99 109 5376 5386 B-cancer
, 109 110 5386 5387 O
patients 111 119 5388 5396 O
must 120 124 5397 5401 O
not 125 128 5402 5405 O
be 129 131 5406 5408 O
receiving 132 141 5409 5418 O
other 142 147 5419 5424 O
specific 148 156 5425 5433 B-treatment
treatment 157 166 5434 5443 I-treatment
( 167 168 5444 5445 O
chemotherapy 168 180 5445 5457 B-treatment
, 180 181 5457 5458 O
hormonal 182 190 5459 5467 B-treatment
therapy 191 198 5468 5475 I-treatment
, 198 199 5475 5476 O
radiation 200 209 5477 5486 B-treatment
) 209 210 5486 5487 O
for 211 214 5488 5491 O
their 215 220 5492 5497 O
cancer 221 227 5498 5504 O

patients 0 8 5505 5513 O
known 9 14 5514 5519 O
to 15 17 5520 5522 O
be 18 20 5523 5525 O
HIV 21 24 5526 5529 B-chronic_disease
positive 25 33 5530 5538 O
, 33 34 5538 5539 O
but 35 38 5540 5543 O
without 39 46 5544 5551 O
clinical 47 55 5552 5560 O
evidence 56 64 5561 5569 O
of 65 67 5570 5572 O
an 68 70 5573 5575 O
immunocompromised 71 88 5576 5593 O
state 89 94 5594 5599 O
, 94 95 5599 5600 O
are 96 99 5601 5604 O
eligible 100 108 5605 5613 O
for 109 112 5614 5617 O
this 113 117 5618 5622 O
trial 118 123 5623 5628 O

patients 0 8 5629 5637 O
with 9 13 5638 5642 O
oncocytic 14 23 5643 5652 O
( 24 25 5653 5654 O
Hurthle 25 32 5654 5661 O
cell 33 37 5662 5666 O
) 37 38 5666 5667 O
variants 39 47 5668 5676 O
of 48 50 5677 5679 O
papillary 51 60 5680 5689 B-cancer
thyroid 61 68 5690 5697 I-cancer
carcinoma 69 78 5698 5707 I-cancer
( 79 80 5708 5709 O
defined 80 87 5709 5716 O
as 88 90 5717 5719 O
a 91 92 5720 5721 O
tumor 93 98 5722 5727 B-cancer
composed 99 107 5728 5736 O
of 108 110 5737 5739 O
a 111 112 5740 5741 O
majority 113 121 5742 5750 O
of 122 124 5751 5753 O
oncocytic 125 134 5754 5763 O
[ 135 136 5764 5765 O
Hurthle 136 143 5765 5772 O
] 143 144 5772 5773 O
cells 145 150 5774 5779 O
having 151 157 5780 5786 O
the 158 161 5787 5790 O
nuclear 162 169 5791 5798 O
features 170 178 5799 5807 O
of 179 181 5808 5810 O
papillary 182 191 5811 5820 B-cancer
carcinoma 192 201 5821 5830 I-cancer
) 201 202 5830 5831 O
are 203 206 5832 5835 O
eligible 207 215 5836 5844 O
to 216 218 5845 5847 O
participate 219 230 5848 5859 O

